Undiscovered pathology of transient scaffolding t1remains a driver of failures in clinical trials

doi:10.4330/wjc.v10.i10.165

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8711)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

474

WORD

180

HTML

5647

Figures (1-7)

643

Tables (1-2)

295

Sum=7239

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

634

Download

838

Sum=1472

Oct 26, 2018 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Review

World J Cardiol. Oct 26, 2018; 10(10): 165-186
Published online Oct 26, 2018. doi: 10.4330/wjc.v10.i10.165

Full Size Figure Download Figure

Figure 1 Performance of bioresorbable vascular scaffolds in the market. A schematic representation of the Gartner Hype Cycle for the bioresorbable vascular scaffold.

Citation: Kharlamov AN. Undiscovered pathology of transient scaffolding t1remains a driver of failures in clinical trials. World J Cardiol 2018; 10(10): 165-186
URL: https://www.wjgnet.com/1949-8462/full/v10/i10/165.htm
DOI: https://dx.doi.org/10.4330/wjc.v10.i10.165